‹ All stocks
Drugs Made In America Acquisition Corp. Ordinary Shares
DMAA · NASDAQ · Financial Services
$10.88
▼ $10.88 (-0.18%)
Day range
$10.81 – $10.90
Year range
$10.26 – $10.90
Open
$10.90
Previous close
—
Market cap
$264.13M
Volume (24h)
—
Volume (52w)
—
Performance
7D
— 0.00%
1M
▲ 1.12%
3M
▲ 2.06%
6M
▲ 3.52%
1Y
▲ 5.94%
YTD
▲ 4.82%
3Y
▲ 9.24%
5Y
▲ 9.24%
All-time
▲ 9.24%
Key statistics
P/E ratio
—
EPS (TTM)
—
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
24.3M
About Drugs Made In America Acquisition Corp. Ordinary Shares
Drugs Made In America Acquisition Corp. functions as a special purpose acquisition company, commonly known as a blank check company. Its core mission is to seek out and ultimately acquire one or more existing businesses or their assets. This acquisition strategy encompasses a variety of transactional methods, such as corporate mergers, capital stock exchanges, direct asset purchases, stock acquisitions, or broader corporate reorganizations.
Visit websiteCountry: United States of America
More in Financial Services
BRK-B Berkshire Hathaway |
$500.50 | 0.51% |
JPM JPMorgan Chase & Co. |
$333.18 | 0.71% |
V Visa |
$359.85 | 0.14% |
MA Mastercard Incorporated |
$550.00 | -0.27% |
BAC Bank of America |
$53.73 | -1.29% |